Skip Main Navigation
Page Content

Save This Event

Event Saved

The Value of a Biotechnology Business

JLABS Bay Area

Tuesday, March 7, 2017 from 9:45 AM to 12:00 PM (PST)

The Value of a Biotechnology Business

Ticket Information

Ticket Type Sales End Price Fee Quantity
Presentation & Lunch Only   more info Mar 6, 2017 $25.00 $2.37
Volunteer   more info Mar 6, 2017 Free $0.00

Share The Value of a Biotechnology Business

Event Details

Biotech companies... do you know your worth? The wise startup company plans their exit from the beginning. In order to properly leverage your exit value you need to understand the different valuation methods, how they are used and who is using them.

John Selig, Managing Partner and co-founder of Mavericks Capital, a healthcare investment bank, will guide you through the maze of sunk costs, sum of parts, comparables, Discounted Cash Flow (DTC) and Net Present Value (NPV) to help you increase negotiating leverage and make more informed funding decisions.

Join us for an informative and interactive session.

    Topics Covered
  • The different valuation methodologies and who is using them
  • Key approaches in funding for life science companies
  • Planning exit strategies and deal structuring from the outset
  • How do my expected deal terms relate to my forecast cash flows and how can I use this to make better decisions on licensing timing?


In cooperation with BioPharma Consortium. Visit www.Biopharmaconsortium.com for more information.


Agenda:
9:45am | Registration
10:00am | Presentation and Q&A
11:30am | Lunch and Networking
12:00 | Program close


Speakers:
John Selig | Managing Partner, Mavericks Capital
John advises life science companies on M&A, licensing and financial strategy. He speaks frequently on topics in valuation, deal term benchmarking, and strategy in the life sciences space, including the Valuation and Finance module at BIO's Executive Management Training course for BD professionals each year and the Valuation lecture at Stanford Medical School's Entrepreneurship Program. Prior to joining Maverick's, John co-led the Life Sciences Group at Woodside Capital Partners, a boutique investment bank. For the prior 12 years, he advised both Fortune 100 and VC - backed healthcare companies on transaction strategy and valuation at Strategic Decisions Group (SDG), a global management consulting firm, and Keelin Reeds Partners, a life sciences consulting firm. While at Keelin Reeds, John led a partnership and M&A deal term benchmarking effort and has extensive experience in applying that data to yield market-value deal terms for dozens of assets, using the results to provide ongoing support during deal negotiations. Prior to consulting, John was an attorney with Weil, Gotshal and Manges where he focused on M&A and corporate finance. John holds a JD from Stanford Law School, where he was an Associate Editor of Law Review, and a BA, magna cum laude, from Brown University, where he was a member of Phi Beta Kappa (FINRA 24, 63, 79).


Fees:
Presentation
$25 | General Public
$35 | Onsite


Venue:
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Have questions about The Value of a Biotechnology Business? Contact JLABS Bay Area

Save This Event

Event Saved

When & Where


Johnson & Johnson Innovation, JLABS
329 Oyster Point Blvd
3rd Floor
South San Francisco, CA

Tuesday, March 7, 2017 from 9:45 AM to 12:00 PM (PST)


  Add to my calendar

Organizer

JLABS Bay Area

JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.